皮肤科门诊患者焦虑障碍患病率的系统综述与Meta分析
该系统综述与Meta分析检索了PubMed、Embase、Cochrane和PsycINFO,纳入32项研究共12812名皮肤科门诊患者,随机效应模型估计焦虑患病率为26.7%(95%CI 22.4-31.4;95%PI 9.7-55.4)。亚组分析显示银屑病患者研究中的患病率高于一般皮肤科研究,自评筛查工具评估的患病率高于诊断性访谈。作者鼓励皮肤科医生关注焦虑对门诊患者的影响并识别和支持焦虑患者。
要点
- 皮肤科门诊患者焦虑患病率估计为26.7%(95%CI 22.4-31.4)。
- 银屑病患者研究中的焦虑患病率高于一般皮肤科研究。
- 自评筛查评估的患病率高于诊断性访谈评估。
核心结论
- 焦虑在皮肤科门诊患者中常见,尤其在银屑病门诊患者中,患病率高于普通人群的常见估计值。
- 鉴于焦虑对患者结局和福祉的影响,作者鼓励皮肤科医生考虑焦虑如何影响其门诊患者,以及如何最好地识别焦虑患者并随后支持他们。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、Embase、Cochrane和PsycINFO,最后检索日期为2022年9月7日。
- 纳入16岁及以上、能代表皮肤科门诊的患者研究,共识别5423项研究,最终纳入32项,总样本量n=12812名参与者。
- 使用Joanna Briggs Institute Critical Appraisal Checklist评估偏倚风险,使用CMA软件进行Meta分析,并对相关变量进行亚组分析。
主要发现
- 随机效应模型下,焦虑患病率估计为26.7%(95%CI 22.4-31.4;95%PI 9.7-55.4)。
- 亚组分析显示,银屑病患者研究中的患病率高于一般皮肤科研究。
- 通过自评筛查评估的患病率估计高于通过诊断性访谈评估的患病率。
关键数值与推荐
- 随机效应模型下焦虑患病率为26.7%(95%CI 22.4-31.4;95%PI 9.7-55.4)。
- 亚组分析:银屑病患者研究中的焦虑患病率高于一般皮肤科研究。
- 亚组分析:自评筛查评估的患病率高于诊断性访谈评估。
临床怎么用
- 作者鼓励皮肤科医生考虑焦虑如何影响其门诊患者,以及如何最好地识别焦虑患者并随后支持他们。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Anxiety is common in those with medical conditions and has significant impacts on mental well-being as well as physical health outcomes. While several systematic reviews have examined the prevalence of anxiety in specific dermatological conditions, no reviews have examined the prevalence across the entire dermatology outpatient setting. This systematic review aims to provide an overview to dermatologists of the prevalence of, and trends in, anxiety in their outpatient clinics. As such, prevalence of anxiety in dermatology outpatient clinics was examined, and variations across type of anxiety and dermatological conditions were assessed. A search of PubMed, Embase, Cochrane and PsycINFO was conducted for studies that assessed anxiety prevalence in dermatology outpatients, with the last search conducted on 7 September 2022. Results underwent title/abstract and full-text screening, followed by data extraction. Studies of patients 16 years and older and representative of dermatology clinics were included. Risk of bias was assessed using Joanna Briggs Institute Critical Appraisal Checklist. Meta-analysis was conducted using CMA software, and subgroup analysis was conducted on relevant variables. 5423 studies were identified, and 32 included, with a total n = 12,812 participants. Under the random effects model, prevalence was estimated at 26.7% (95%CI 22.4-31.4; 95%PI 9.7-55.4). Subgroup analysis revealed a higher prevalence among studies of psoriasis patients than general dermatology studies. Estimates of prevalence were higher when assessed via self-report screening than diagnostic interview. Anxiety occurred frequently among dermatology outpatients, especially psoriasis outpatients, at a higher rate than common estimates of prevalence in the general population. Given the effect of anxiety on patient outcomes and well-being, dermatologists are encouraged to consider how anxiety may impact patients in their clinic, and how they can best identify patients with anxiety and subsequently support them.
引用
- Storer B, Kershaw KA, Braund TA, et al. The prevalence of anxiety disorders in dermatology outpatients: A systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2023. PMID: 37118899. doi:10.1111/jdv.19151
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。